Investor Overview

Corporate Profile

Investor Highlights

Corporate Profile

Read Now
Corporate Profile

Investor Presentation

Read Now
highlightbg1

Our Pipeline

Learn More
highlightbg2
  • Price
  • Change

  • Copyright West LLC.
    Minimum 15 minutes delayed.
Recent Releases

Recent Releases

May 16, 2019

BeiGene Announces Clinical Data on Tislelizumab and Zanubrutinib to be Presented at the 24th Congress of the European Hematology Association

May 9, 2019

BeiGene Reports First Quarter 2019 Financial Results

April 9, 2019

BioAtla and BeiGene Form Worldwide Collaboration to Develop and Commercialize Novel Conditionally Active Biologic CTLA-4 Therapy

Key Metrics

Key Metrics

  • 2,400

    Employees

  • 800+

    Clinical team

  • 4

    Continents

Latest Events

Mar 13, 2019 at 3:20 PM EDT

BeiGene, Ltd. at the Barclay’s Global Healthcare Conference

Mar 11, 2019 at 4:10 PM EDT

BeiGene, Ltd. at the Cowen and Company 39th Annual Health Care Conference

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

Accept